Leading the way in the research and production of 3D cell culture solutions

Who are we?

We are a young, innovative, research-led company that designs, develops and creates novel solutions to tissue culture limitations to meet your research needs.

What is our Company Mission?

The Company’s mission is to provide bespoke products that allow our customers to fully exploit the in-vitro culture of cells in applications related to regenerative medicine, diseases such as cancer and diabetes, in-vitro drug screening and for incorporation into bioinks.

What is different about our products?

  • Our PhenoDrive products promote the formation of 3D cell spheroids from 2D culture systems without need for gels.
  • PhenoDrives are animal component free and are provided as lyophilised powders that are easily reconstituted and incorporated into your existing protocols.
  • PhenoDrives are a range of fully synthetic, biomimetic materials to provide simple, single step solutions to promote your cell culture models and preserve phenotype through mimicry of the extra cellular matrix.
  • Nanosperse allows the simple dispersal of nanoparticles for individual testing and study

Where are we based?

We are based in the city of Brighton and Hove, East Sussex, England

CONTACT US
1

2011

Company registered
2

2014

Grant awarded from Innovate UK
3

2014

Beta Testing begins on PhenoDrive-R and PhenoDrive-U
4

2015

Cell-Based Models for Neurodegeneration Study and Use in Screening (CENSUS) awarded under the H2020-Fast Track to Innovation call.
5

2016

H2020-FTIPilot 730678 CENSUS project begins
6

2016

PhenoDrive-R and PhenoDrive-U product launch
7

2016

Beta Testing begins on PhenoDrive-Y
8

2017

PhenoDrive-Y product launch
9

2017

Beta Testing begins on PhenoDrive-I
10

2018

New large grant awarded - announcement coming soon!
11

Jan 2019

EU signing of the RESTORE Health by Advanced Therapies
12

May 2019

H2020 MEFISTO project launch - https://www.mefisto-project.eu
13

June 2019

New development and manufacturing facilities open for business

Funded By

Horizon 2020 European Funding for Research & Innovation

Along with three other partners we are working on the CENSUS project which is working towards providing a technical solution for neurodegenerative disorders. The project will produce CNS cell models from a consistent, renewable source, in the form of induced pluripotent stem cells (iPSC); will manufacture 3D scaffolds in multiwell culture plates by micro-extrusion technology.

Our Key Team

Discover the TissueClick staff credentials

Dr Anna Guildford

Exploitation Manager

Dr Guildford is the Exploitation Manager at Tissue Click Ltd. Anna has over 18 years of experience in the field of cell biology, tissue engineering and regeneration. She joined Tissue Click Ltd in October 2017 where she has since lead the development, manufacture and more recently the exploitation of the PhenoDrive product portfolio.

Dr Gary Phillips

Innovation Manager

Dr Phillips is the Innovation Manager for Tissue Click Ltd. Gary has over 25 years of experience in the fields of biomaterials, drug delivery and tissue engineering. He has published over 70 papers in peer-reviewed journals and filed a number of patents in the biomaterials and drug-delivery fields. He joined Tissue click Ltd in November 2017 and has since lead their business development strategy and the commercialisation of the PhenoDrive product family.

Want to discuss your project further with the TissueClick team?  Contact us

TRY PHENODRIVE TODAY

Contact us to order